Overview
The primary goal in
modern Head and Neck oncology is "Organ Preservation"—curing the
malignancy while safeguarding the patient’s ability to speak, swallow, and
interact socially. Transoral Robotic Surgery (TORS) is at the forefront of this
evolution, offering a sophisticated alternative to traditional open
"jaw-splitting" surgeries.
The Technology: How TORS Works It Can Occur
The robotic system serves
as a high-tech extension of the surgeon’s hands. It consists of three primary
components:
• The Robotic Arms: Thin tubes equipped with miniaturized
instruments that possess a greater range of motion and rotation than the human
wrist, allowing them to navigate the tightest spaces of the mouth and throat.
• The 3D Endoscope: A high-definition, magnified camera that
provides the surgeon with a depth-perceived, crystal-clear view of the tumour
and surrounding healthy tissue.
• The Surgeon’s Console: A specialized workstation where the
surgeon controls every movement of the instruments with extreme precision and
filtered tremors.
Indications: Who is a Candidate?
TORS is highly effective
for specific areas of the head and neck, typically paired with a neck
dissection to manage lymph nodes. It is primarily recommended for early-stage
cancers in the following regions:
• Oropharynx: Including the tonsils, base of the tongue, and
soft palate.
• Hypopharynx & Supraglottic Larynx: The upper portions of
the throat and voice box.
• Parapharyngeal Space: Tumours located in the deep tissues of
the neck and throat.
Note
While TORS is a revolutionary tool for early-stage disease and organ preservation, it is generally not recommended for advanced-stage cancers where the tumour has extensively invaded deep structures, requiring more radical traditional approaches.